AXA Investment Managers (AXA IM) has appointed an equity analyst in the pharmaceuticals sector, adding to hires which expanded the team earlier this month.

Chris Donnellan joins the pharmaceuticals team from Datamonitor, the market research company, where he led a team doing market reseach into key products on behalf of the pharmaceuticals industry.